These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22930322)

  • 1. Natural product 'legal highs'.
    Arunotayanun W; Gibbons S
    Nat Prod Rep; 2012 Nov; 29(11):1304-16. PubMed ID: 22930322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Legal highs'--novel and emerging psychoactive drugs: a chemical overview for the toxicologist.
    Gibbons S
    Clin Toxicol (Phila); 2012 Jan; 50(1):15-24. PubMed ID: 22248120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single chemical entity legal highs: assessing the risk for long term harm.
    McNabb CB; Russell BR; Caprioli D; Nutt DJ; Gibbons S; Dalley JW
    Curr Drug Abuse Rev; 2012 Dec; 5(4):304-19. PubMed ID: 23244343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of psychoactive and intoxicating substances in legal highs.
    Żukiewicz-Sobczak W; Zwoliński J; Chmielewska-Badora J; Krasowska E; Piątek J; Sobczak P; Wojtyła A; Fornal E; Kuczumow A; Biliński P
    Ann Agric Environ Med; 2012; 19(2):309-14. PubMed ID: 22742807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of the 'legal high' mephedrone.
    Gibbons S; Zloh M
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4135-9. PubMed ID: 20542690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Khat and synthetic cathinones: a review.
    Valente MJ; Guedes de Pinho P; de Lourdes Bastos M; Carvalho F; Carvalho M
    Arch Toxicol; 2014 Jan; 88(1):15-45. PubMed ID: 24317389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence and properties of spice and bath salts: a medicinal chemistry perspective.
    Lewin AH; Seltzman HH; Carroll FI; Mascarella SW; Reddy PA
    Life Sci; 2014 Feb; 97(1):9-19. PubMed ID: 24113072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
    Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
    J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of current trends in the abuse of psychotropic substances and plants in Japan.
    Kikura-Hanajiri R; Uchiyama N; Goda Y
    Leg Med (Tokyo); 2011 May; 13(3):109-15. PubMed ID: 21377397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
    Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
    J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.
    Zawilska JB
    Int Rev Neurobiol; 2015; 120():273-300. PubMed ID: 26070762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Legal highs" from the German internet--"bath salt drugs" on the rise].
    Musshoff F; Hottmann L; Hess C; Madea B
    Arch Kriminol; 2013; 232(3-4):91-103. PubMed ID: 24358620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purchasing 'legal highs' on the Internet--is there consistency in what you get?
    Davies S; Wood DM; Smith G; Button J; Ramsey J; Archer R; Holt DW; Dargan PI
    QJM; 2010 Jul; 103(7):489-93. PubMed ID: 20413562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Legal highs" - new players in the old drama.
    Zawilska JB
    Curr Drug Abuse Rev; 2011 Jun; 4(2):122-30. PubMed ID: 21711229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
    Liechti M
    Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenge of a ban on animal testing for the development of a regulated legal market for new psychoactive substances (NPS) ('legal highs') in New Zealand: Issues and options for resolution.
    Rychert M; Wilkins C
    Int J Drug Policy; 2015 Dec; 26(12):1273-8. PubMed ID: 26364077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New synthetic drugs in addictovigilance.
    Chavant F; Boucher A; Le Boisselier R; Deheul S; Debruyne D
    Therapie; 2015; 70(2):167-89. PubMed ID: 25858573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances ('legal highs') in New Zealand.
    Rychert M; Wilkins C; Witten K
    Drug Alcohol Rev; 2017 Sep; 36(5):589-596. PubMed ID: 28229493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential utility of some legal highs in CNS disorders.
    Davidson C; Schifano F
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():267-74. PubMed ID: 26232510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.